시장보고서
상품코드
1791467

세계의 동물 혈액 및 혈액 성분 시장

Animal Blood & Blood Components

발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 174 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 동물 혈액 및 혈액 성분 시장은 2030년까지 2억 6,320만 달러에 이를 전망

2024년에 1억 5,820만 달러로 추정된 동물 혈액 및 혈액 성분 세계 시장은 2024-2030년 분석 기간에 CAGR 8.9%로 성장하여 2030년에는 2억 6,320만 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 동물 혈액 성분은 CAGR 10.6%를 나타내고, 분석 기간 종료시에는 1억 5,570만 달러에 이를 것으로 예측됩니다. 동물 전혈 부문의 성장률은 분석 기간중 CAGR 6.7%로 추정됩니다.

미국 시장은 4,160만 달러로 추정되는 한편, 중국은 CAGR 8.5%를 보일 것으로 예측된다

미국의 동물 혈액 및 혈액 성분 시장은 2024년에는 4,160만 달러로 추정됩니다. 세계 2위 경제대국인 중국은2024-2030년의 분석 기간에 CAGR 8.5%로 성장하여 2030년까지 예측 시장 규모 4,180만 달러에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 8.3%와 7.3%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 약 6.9%를 보일 전망입니다.

세계의 동물 혈액 및 혈액 성분 시장 - 주요 동향과 촉진요인 정리

다양한 산업에서 동물의 혈액과 혈액 성분에 대한 수요가 증가하는 이유는 무엇일까?

동물의 혈액과 그 성분에 대한 수요는 의약품, 동물사료, 식품 가공, 진단 등 다양한 용도로 사용되기 때문에 다양한 산업에서 증가하고 있습니다. 혈장, 헤모글로빈, 혈청 단백질과 같은 동물 혈액 유도체의 백신, 치료 제품, 바이오 의약품 생산에 대한 사용 증가는 시장 성장을 가속하는 중요한 요인입니다. 또한, 동물사료 산업도 중요한 소비자로 부상하고 있으며, 혈액 식사 및 혈장 단백질은 가축의 영양과 성장을 향상시키기 위한 고단백 영양 보충제로 사용되고 있습니다. 또한 식품 가공 업계는 풍부한 아미노산과 단백질 함량을 이용하여 기능성 식품 및 영양 보충제 제조에 동물의 혈액 성분을 도입하고 있습니다. 지속 가능한 자원 활용에 대한 인식이 높아지면서 동물 혈액 제품별로 혁신적인 용도를 찾고, 폐기물을 줄이고, 동물 가공에서 얻을 수 있는 가치를 극대화하기 위해 업계가 더욱 박차를 가하고 있습니다.

기술 발전은 어떻게 시장 혁신을 촉진하고 있는가?

처리 및 분리 기술의 기술 발전은 동물 혈액 성분의 생산과 응용에 혁명을 가져왔습니다. 분획 및 정제 공정의 기술 혁신은 기능적 특성이 강화된 고부가가치 단백질과 생리활성 화합물을 추출하여 생명공학 및 제약 분야의 특수 용도에 적합하게 만들고 있습니다. 또한, 첨단 멸균 및 보존 기술을 채택하여 혈액 유래 제품의 보존 기간과 안정성을 향상시키고, 최종 사용자에게 품질과 효능을 보장합니다. 또한, 생명공학 및 분자생물학 연구를 통해 면역글로불린이 풍부한 혈장 및 동물혈액 유래 생리활성 펩타이드와 같은 새로운 제품 개발을 촉진하여 면역 건강, 상처 치유, 영양보충제 등에 응용할 수 있습니다. 이러한 기술적 진보가 계속 발전함에 따라 제조업체들은 제품의 일관성 향상, 처리 비용 절감, 각 지역의 규제 요건을 충족하기 위한 안전 기준 강화에 초점을 맞추었습니다.

동물 혈액 및 혈액 성분 시장에는 어떤 과제와 기회가 존재할까?

동물 혈액 및 혈액 성분 시장은 규제 장애물, 윤리적 문제, 원료 공급의 불균형 등 여러 가지 문제에 직면해 있습니다. 특히 식품 산업과 제약 산업에서 동물성 원료의 수집, 가공, 사용을 규정하는 엄격한 규제 프레임워크는 시장 관계자들에게 컴플라이언스 이슈가 되고 있습니다. 동물 복지 및 혈액제제 조달과 관련된 윤리적 문제도 업계 이해관계자들에게 보다 투명하고 지속 가능한 조달 관행을 채택할 것을 촉구하고 있습니다. 또한, 오염 및 질병 전파의 잠재적 위험은 엄격한 품질 관리 조치를 필요로 하며, 업무의 복잡성을 더욱 증가시킵니다. 그러나 이러한 도전은 기술 혁신과 시장 차별화의 기회를 제공합니다. 대체 단백질 공급원에 대한 관심 증가, 클린 라벨 및 지속 가능한 원료에 대한 수요 증가, 생체 재료 및 재생 의학 분야의 연구 확대는 동물 혈액 유래 제품에 대한 유망한 성장 수단을 제공합니다. 친환경 가공 기술과 강력한 추적 시스템에 투자하는 기업은 진화하는 시장에서 새로운 기회를 활용할 수 있는 유리한 위치에 있습니다.

동물 혈액 및 혈액 성분 시장의 성장을 가속하는 주요 요인은?

동물 혈액 및 혈액 성분 시장의 성장은 고단백 동물사료 수요 증가, 의약품에 대한 적용 확대, 식품 가공에 대한 활용 확대 등 여러 요인에 의해 이루어집니다. 세계 인구 증가와 효율적인 축산에 대한 요구가 증가함에 따라 동물의 건강과 생산성을 향상시키는 혈액 기반 사료 첨가제에 대한 수요가 증가하고 있습니다. 제약업계가 백신 생산, 세포배양 배지, 바이오 의약품 개발을 위해 혈액 유래 단백질에 대한 의존도를 높이고 있는 것도 주요 촉진요인입니다. 또한, 동물의 혈액 성분을 함유한 기능성 식품 및 건강기능식품 증가 추세도 시장 확대에 기여하고 있습니다. 지속 가능한 자원 이용을 촉진하기 위한 정부의 이니셔티브와 가공 기술의 발전은 향후 몇 년 동안 시장 성장을 더욱 가속화할 것으로 예측됩니다.

부문

유형(동물 혈액 성분, 동물 전혈), 동물 사이즈(대형 동물, 소형 동물), 용도(빈혈 용도, 외과 용도, 출혈성 질환 용도, 기타 용도)

조사 대상 기업 예

  • Animal Technologies, Inc.
  • Biowest SAS
  • Bovogen Biologicals Pty Ltd.
  • Kraeber & Co GmbH
  • Lake Immunogenics, Inc.
  • LAMPIRE Biological Laboratories, Inc.
  • PAN-Biotech GmbH
  • Pel-Freez, LLC
  • Rocky Mountain Biologicals, LLC
  • Serana Europe GmbH
  • TCS Biosciences Ltd.
  • Thermo Fisher Scientific, Inc.

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

LSH 25.08.22

Global Animal Blood & Blood Components Market to Reach US$263.2 Million by 2030

The global market for Animal Blood & Blood Components estimated at US$158.2 Million in the year 2024, is expected to reach US$263.2 Million by 2030, growing at a CAGR of 8.9% over the analysis period 2024-2030. Animal Blood Components, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$155.7 Million by the end of the analysis period. Growth in the Animal Whole Blood segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$41.6 Million While China is Forecast to Grow at 8.5% CAGR

The Animal Blood & Blood Components market in the U.S. is estimated at US$41.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$41.8 Million by the year 2030 trailing a CAGR of 8.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.3% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.9% CAGR.

Global Animal Blood & Blood Components Market - Key Trends & Drivers Summarized

Why Is Demand for Animal Blood & Blood Components Increasing Across Various Industries?

The demand for animal blood and its components is rising across multiple industries due to its wide-ranging applications in pharmaceuticals, animal feed, food processing, and diagnostics. The increasing use of animal blood derivatives such as plasma, hemoglobin, and serum proteins in the production of vaccines, therapeutic products, and biopharmaceuticals is a key factor driving market growth. The animal feed industry has also emerged as a significant consumer, with blood meal and plasma proteins being used as high-protein dietary supplements to enhance livestock nutrition and growth. In addition, the food processing industry is incorporating animal blood components in the production of functional foods and nutritional supplements, leveraging their rich amino acid and protein content. The growing awareness of sustainable resource utilization is further encouraging industries to explore innovative applications of animal blood by-products, reducing waste and maximizing value from animal processing.

How Are Technological Advancements Driving Innovation in the Market?

Technological advancements in processing and separation techniques are revolutionizing the production and application of animal blood components. Innovations in fractionation and purification processes are enabling the extraction of high-value proteins and bioactive compounds with enhanced functional properties, making them suitable for specialized applications in biotechnology and pharmaceuticals. The adoption of advanced sterilization and preservation technologies is also improving the shelf life and stability of blood-derived products, ensuring their quality and efficacy for end-users. Additionally, research in biotechnology and molecular biology is facilitating the development of novel products such as immunoglobulin-rich plasma and bioactive peptides derived from animal blood, offering potential benefits for immune health, wound healing, and nutraceutical applications. As these technological advancements continue to evolve, manufacturers are focusing on improving product consistency, reducing processing costs, and enhancing safety standards to meet regulatory requirements across different regions.

What Challenges and Opportunities Exist in the Animal Blood & Blood Components Market?

The animal blood and blood components market faces several challenges, including regulatory hurdles, ethical concerns, and variability in raw material supply. Stringent regulatory frameworks governing the collection, processing, and use of animal-derived materials, particularly in the food and pharmaceutical industries, present compliance challenges for market players. Ethical concerns related to animal welfare and the sourcing of blood products have also prompted industry stakeholders to adopt more transparent and sustainable sourcing practices. Additionally, the potential risks of contamination and disease transmission require rigorous quality control measures, further adding to operational complexities. However, these challenges present opportunities for innovation and market differentiation. The increasing focus on alternative protein sources, growing demand for clean-label and sustainable ingredients, and the expansion of research in biomaterials and regenerative medicine offer promising growth avenues for animal blood-derived products. Companies investing in eco-friendly processing technologies and robust traceability systems are well-positioned to capitalize on emerging opportunities in this evolving market.

What Are the Key Factors Driving Growth in the Animal Blood & Blood Components Market?

The growth in the Animal Blood & Blood Components market is driven by several factors, including the rising demand for high-protein animal feed, expanding applications in pharmaceuticals, and increasing utilization in food processing. The growing global population and the rising need for efficient livestock production are fueling the demand for blood-based feed additives that enhance animal health and productivity. The pharmaceutical industry's increasing reliance on blood-derived proteins for vaccine production, cell culture media, and biopharmaceutical development is another major growth driver. Additionally, the growing trend of functional foods and dietary supplements incorporating animal blood components is contributing to market expansion. Government initiatives promoting sustainable resource utilization and advancements in processing technologies are expected to further accelerate market growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Animal Blood & Blood Components market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Animal Blood Components, Animal Whole Blood); Animal Size (Large Animals, Small Animals); Application (Anemia Application, Surgery Application, Bleeding Disorders Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • Animal Technologies, Inc.
  • Biowest SAS
  • Bovogen Biologicals Pty Ltd.
  • Kraeber & Co GmbH
  • Lake Immunogenics, Inc.
  • LAMPIRE Biological Laboratories, Inc.
  • PAN-Biotech GmbH
  • Pel-Freez, LLC
  • Rocky Mountain Biologicals, LLC
  • Serana Europe GmbH
  • TCS Biosciences Ltd.
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Animal Blood & Blood Components - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Animal-Derived Proteins in Pharmaceuticals and Biotechnology Propels Growth in the Animal Blood and Blood Components Market
    • Increasing Use of Animal Blood Plasma in Functional Foods and Nutraceuticals Expands Market Opportunities
    • Growing Demand for Blood-Derived Proteins in Cell Culture Media Strengthens Business Case for Animal Blood Components in Biopharmaceutical Research
    • Expansion of the Pet Food Industry Spurs the Use of Animal Blood Components in High-Protein and Specialty Pet Nutrition
    • Technological Advancements in Blood Fractionation and Processing Enhance the Yield and Purity of Animal Blood Components
    • Rising Adoption of Animal Blood Components in Veterinary Medicine and Diagnostics Fuels Market Expansion
    • Increasing Demand for Hemoglobin-Based Oxygen Carriers (HBOCs) Throws the Spotlight on Animal Blood as a Source of Artificial Blood Substitutes
    • Surging Interest in Sustainable and Zero-Waste Meat Processing Strengthens Utilization of Animal Blood By-Products
    • Growing Applications in the Leather Industry Propel Demand for Animal Blood-Derived Proteins in Tanning and Biopolymer Production
    • Regulatory Approvals and Quality Standards Influence Product Development and Safety Compliance in the Animal Blood Components Market
    • Increasing Use of Animal Blood Extracts in Traditional Medicine and Herbal Formulations Expands Addressable Market
    • Rising Investments in Alternative Protein Sources Encourage Research into Animal Blood-Derived Functional Ingredients
    • Growing Concerns Over Zoonotic Diseases Drive Innovations in Pathogen-Free Processing of Animal Blood and Blood Components
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Animal Blood & Blood Components Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Animal Blood & Blood Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Animal Blood Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Animal Blood Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Animal Whole Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Animal Whole Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Large Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Large Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Small Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Small Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Anemia Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Anemia Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Surgery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Bleeding Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Bleeding Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Animal Blood & Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Animal Blood & Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030
  • CHINA
    • Animal Blood & Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Animal Blood & Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Animal Blood & Blood Components by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030
  • FRANCE
    • Animal Blood & Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 52: France Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Animal Blood & Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Animal Blood & Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 70: UK Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Animal Blood & Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제